Video

VIDEO: Dr. Alexis Ogdie discusses the latest research in psoriatic arthritis


 

What's new with potential treatment options such as tildrakizumab? Given the roles obesity and metabolic disease play in psoriatic arthritis, how does weight loss affect treatment response? Alexis Ogdie, MD, director of the psoriatic arthritis clinic at the University of Pennsylvania in Philadelphia, talks about the latest developments in psoriatic arthritis research.

Recommended Reading

VIDEO: Dr. Lihi Eder on the diagnostic challenges of psoriatic arthritis
Psoriatic Arthritis ICYMI
Obesity might be targetable driver of psoriatic arthritis progression
Psoriatic Arthritis ICYMI
Systemic psoriasis treatments less often prescribed in elderly with psoriasis, despite comparable response rates
Psoriatic Arthritis ICYMI
Infections linked with transition to psoriatic arthritis
Psoriatic Arthritis ICYMI
Psoriatic Arthritis Journal Scan: June 2019
Psoriatic Arthritis ICYMI
PsA Fast Facts: PsA and psoriasis links
Psoriatic Arthritis ICYMI
EULAR keeps csDMARDs as top PsA drugs
Psoriatic Arthritis ICYMI
Unacceptable pain despite inflammation control commonly occurs in PsA patients
Psoriatic Arthritis ICYMI
Flu vaccine succeeds in TNF inhibitor users
Psoriatic Arthritis ICYMI
Ixekizumab boosts quality of life in genital psoriasis
Psoriatic Arthritis ICYMI